Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
VERV
Shares outstanding
89,600,000
Price per share
$11.23
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
115,958
Total reported value
$1,373,904
% of total 13F portfolios
0%
Share change
-72,274,589
Value change
-$811,683,576
Number of holders
6
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Pentwater Capital Management LP 7.5% $74,793,600 6,720,000 Pentwater Capital Management LP 30 Jun 2025
BlackRock, Inc. 7% $33,730,520 6,177,751 BlackRock, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 4.9% +6% $23,626,659 +$2,228,204 4,327,227 +10% Millennium Management LLC 22 Apr 2025
STATE STREET CORP 3.8% $17,667,179 3,235,747 STATE STREET CORPORATION 31 Dec 2024
As of 30 Sep 2025, Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) has 6 institutional shareholders filing 13F forms. They hold 115,958 shares. of 89,600,000 outstanding shares (0.13%) .

Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 115,958 $1,373,904 -$811,683,576 $11.23 6
2025 Q2 72,945,086 $819,295,389 +$44,434,673 $11.23 171
2025 Q1 80,771,198 $369,085,158 +$7,858,760 $4.57 189
2024 Q4 78,639,409 $443,556,247 +$18,374,947 $5.64 162
2024 Q3 75,254,197 $364,246,240 -$6,877,085 $4.84 169
2024 Q2 76,097,271 $371,356,824 -$40,940,545 $4.88 161
2024 Q1 81,620,346 $1,084,037,472 +$94,948,209 $13.28 160
2023 Q4 74,728,462 $1,041,701,866 +$151,177,198 $13.94 153
2023 Q3 63,876,196 $847,014,395 +$20,551,038 $13.26 129
2023 Q2 61,868,280 $1,159,985,777 -$19,845,731 $18.75 117
2023 Q1 63,279,802 $911,809,584 +$3,329,291 $14.42 122
2022 Q4 62,650,868 $1,212,293,655 +$9,165,340 $19.35 119
2022 Q3 60,715,323 $2,083,329,620 +$500,673,254 $34.35 120
2022 Q2 45,570,006 $695,801,719 -$28,487,829 $15.28 95
2022 Q1 46,647,422 $1,064,194,664 +$20,310,755 $22.82 91
2021 Q4 45,147,057 $1,662,481,200 +$125,426,175 $36.87 89
2021 Q3 38,717,676 $1,813,712,011 +$21,671,136 $47.00 72
2021 Q2 37,677,821 $2,254,528,000 +$2,254,527,999 $60.25 69